Jiuzhou Pharmaceutical (603456.SH) released its performance for the first three quarters, with net profit attributable to the parent company of 617 million yuan, a year-on-year decrease of 17.50%.

Zhitong Finance APP News, Jiuzhou Pharmaceutical (603456.SH) disclosed its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 3.937 billion yuan, a year-on-year decrease of 5.38%; net profit attributable to the parent company was 617 million yuan, a year-on-year decrease of 17.50%; net profit after deducting non-recurring gains and losses was 615 million yuan, a year-on-year decrease of 17.54%; basic earnings per share were 0.69 yuan.